These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15361180)

  • 41. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma.
    Gao P; Zhou GY; Yin G; Liu Y; Liu ZY; Zhang J; Hao CY
    Hum Pathol; 2006 Jun; 37(6):719-25. PubMed ID: 16733213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical carcinoma: assessment of parametrial invasion and lymph node metastasis with magnetic resonance imaging.
    Sheu MH; Chang CY; Wang JH; Yen MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):634-40. PubMed ID: 10969450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Morphologic factors influencing the prognosis of squamous-cell cervical cancer].
    Kosnikov AG; Chepik OF; Maksimov SIa
    Vopr Onkol; 1998; 44(2):167-9. PubMed ID: 9615820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.
    Güllü IH; Marangoz S
    Br J Cancer; 1999 Aug; 80(11):1865. PubMed ID: 10468311
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New staging system for uterine cervical neoplasms].
    Saito T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):207-10. PubMed ID: 21452577
    [No Abstract]   [Full Text] [Related]  

  • 52. [Multivariate analysis of histopathologic prognostic factors in invasive cervical carcinoma treated with radical hysterectomy including paraaortic lymphadenectomy].
    Takeda N
    Hokkaido Igaku Zasshi; 2003 Jan; 78(1):67-74. PubMed ID: 12613025
    [No Abstract]   [Full Text] [Related]  

  • 53. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microinvasive carcinoma of the uterine cervix. Risk factors and therapeutic options].
    Gentili C; Calcinai A; Cristofani R
    Minerva Ginecol; 2000 Mar; 52(3):83-92. PubMed ID: 10905081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
    Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
    Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound.
    Pálsdóttir K; Fischerova D; Franchi D; Testa A; Di Legge A; Epstein E
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):470-5. PubMed ID: 25092154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
    Obermair A; Wanner C; Bilgi S; Speiser P; Reisenberger K; Kaider A; Kainz C; Leodolter S; Breitenecker G; Gitsch G
    Cancer; 1998 Feb; 82(4):689-96. PubMed ID: 9477101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.